Following people with lung cancer to see how diet and lifestyle relate to outcomes
Follows adults with lung cancer to study how diet and lifestyle relate to outcomes.
Key facts
- Who runs it
- Shengjing Hospital
- Where
- Shenyang, ChinaSee the site
- Trial code
- Registry title
- The Shengjing Lung Cancer Cohort (SJ-LCC) Study on Risk Factors for Disease Development and Progression
- Status
- Recruiting
- People taking part
- 1,500 people, planned
- Started
- 1 Feb 2019
- Expected to end
- 31 Dec 2029
- Type of study
- Observational
- Record updated
- 21 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 75 with newly confirmed lung cancer, diagnosed in the last 6 months. It studies how diet and lifestyle relate to how the disease develops and progresses.
- Age
- 18 to 75 years
- Sex
- Women and men can both join.
- Disease stage
- Newly diagnosed lung cancer, confirmed by pathology, diagnosed less than 6 months ago.
Main reasons for not taking part
- Lung cancer that is not primary, or not newly diagnosed, or without a clear pathology confirmation
- Poor general physical condition that makes it impossible to answer the questionnaire
- Severe depression
- Pregnancy
- Severe heart, brain blood vessel, liver or kidney disease, or other severe metabolic problems
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Patients aged between 18 and 75 years
- Patients with newly, pathologically confirmed lung cancer
- Patients diagnosed within the preceding 6 months (time since confirmed diagnosis < 6 months)
Who cannot take part
- Patients with non-primary lung cancer, non-newly diagnosed lung cancer, or those unable to provide definitive pathological confirmation
- Individuals with severe depression, pregnant women, or those diagnosed with severe cardiovascular/cerebrovascular diseases or severe metabolic dysfunctions affecting the liver, kidneys, or other major organs
- Individuals aged outside the range of 18-75 years, or those in poor general physical condition who are unable to cooperate with the questionnaire survey
- Individuals unwilling to participate in the study
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Where in China
- Shengjing Hospital affiliated to China Medical UniversityShenyang, ChinaContact: Huanhuan Chen Dr.ChenTaking people
About the trial
What the trial wants to find out
Modifiable risk factors, including smoking, alcohol consumption, and diet, play critical roles in cancer progression and patient prognosis. In patients diagnosed with lung cancer, these risk factors not only directly modulate host metabolism and immune regulation, but also exert indirect effects by altering the internal milieu, such as the gut microbiota-potentially exerting a profound impact on long-term clinical trajectories.
Read full original descriptionShow less
Leveraging a well-characterized, longitudinally followed cohort of confirmed lung cancer patients, this study systematically assesses habitual dietary intake, emotional well-being, lifestyle behaviors, and related variables using validated instruments, including the Food Frequency Questionnaire (FFQ). Furthermore, the study integrates multidimensional biomarker profiling across tumor tissue, blood, urine, and fecal samples. By linking exposure profiles, multi-omics data, and long-term clinical follow-up records, this project aims to:
1. Evaluate Prognostic Associations: Investigate the relationships between exposure profiles (e.g., dietary patterns) and long-term clinical outcomes in lung cancer patients, including progression-free survival (PFS), overall survival (OS), and recurrence risk. 2. Elucidate Biological Mechanisms: Unravel the underlying mechanisms by which the "exposure profile-multi-omics" axis mediates lung cancer progression, and identify candidate biomarkers with predictive value for clinical prognosis.
Ultimately, this study aims to establish evidence-based healthy lifestyle recommendations for patients and provide healthcare professionals with translational insights to inform precision nutrition and targeted intervention strategies across the continuum of lung cancer care.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- The Shengjing Lung Cancer Cohort (SJ-LCC) Study
- Plain-language title
- Following people with lung cancer to see how diet and lifestyle relate to outcomesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Fit questions
- Built from NCT07779005, who can take part
- Record updated
- 21 August 2026